Supreme Court directs government to cap prices of non-patented drugs
The Supreme Court of India has instructed the central government to regulate the prices of non-patented medicines. This directive was issued during a hearing on the high costs of essential drugs. The court emphasized that the government must use its authority to make these vital treatments more affordable. The order aims to address public health concerns by ensuring wider access to necessary medication.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in